Atlas Trials

Dose Optimization and Efficacy Assessment of a Fluoropyrimidine Antidote

Clinical trial NCT07032142 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07032142
Sponsor
D'Or Institute for Research and Education
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
CancerToxicity Due to Chemotherapy
Start date
2025-07-01
Primary completion
2028-07-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.